Safety, tolerability, and immunogenicity of a recombinant toxic shock syndrome toxin (rTSST)-1 variant vaccine: a randomised, double-blind, adjuvant-controlled, dose escalation first-in-man trial. (Record no. 26120089)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01920 a2200517 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517101547.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201706s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1474-4457 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/S1473-3099(16)30115-3 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Schwameis, Michael |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20170612 |
245 00 - TITLE STATEMENT | |
Title | Safety, tolerability, and immunogenicity of a recombinant toxic shock syndrome toxin (rTSST)-1 variant vaccine: a randomised, double-blind, adjuvant-controlled, dose escalation first-in-man trial. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | The Lancet. Infectious diseases |
Date of publication, distribution, etc. | 09 2016 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1036-1044 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adjuvants, Immunologic |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adolescent |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Bacterial Toxins |
General subdivision | isolation & purification |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Double-Blind Method |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Enterotoxins |
General subdivision | isolation & purification |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Healthy Volunteers |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Immunization Schedule |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Immunization, Secondary |
General subdivision | methods |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Shock, Septic |
General subdivision | prevention & control |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Superantigens |
General subdivision | isolation & purification |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vaccination |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vaccines, Synthetic |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Young Adult |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Roppenser, Bernhard |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Firbas, Christa |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gruener, Corina S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Model, Nina |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Stich, Norbert |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Roetzer, Andreas |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Buchtele, Nina |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jilma, Bernd |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Eibl, Martha M |
773 0# - HOST ITEM ENTRY | |
Title | The Lancet. Infectious diseases |
Related parts | vol. 16 |
-- | no. 9 |
-- | p. 1036-1044 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/S1473-3099(16)30115-3">https://doi.org/10.1016/S1473-3099(16)30115-3</a> |
Public note | Available from publisher's website |
No items available.